Xinlei Wei

Dr. Xinlei Wei

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2021 in Science
Verified
Journal Article
Closed access
TCTao Cai
Tao Cai
HSHongbing Sun
Hongbing Sun
JQJing Qiao
Jing Qiao
LZLeilei Zhu
Leilei Zhu
FZFan Zhang
Fan Zhang
YMYanhe Ma
Yanhe Ma
From carbon dioxide to starch: no plants required: Many plants turn glucose from photosynthesis into polymers that form insoluble starch granules ideal for long-term energy storage in roots and seeds. Cai et al . developed a hybrid system in which carbon dioxide is reduced to methanol by an inorganic catalyst and then converted by enzymes first to three and six carbon sugar units and then to polymeric starch. This artificial starch anabolic pathway relies on engineered recombinant enzymes from many different source organisms and can be tuned to produce amylose or amylopectin at excellent rates and efficiencies relative to other synthetic carbon fixation systems—and, depending on the metric used, even to field crops. —MAF

Verified
Journal Article
Open access
PDF file
XWXinlei Wei
Xinlei Wei
HCHo-Yin Chow
Ho-Yin Chow
HCHiu-Chi Chong
Hiu-Chi Chong
SLSiu-Lun Leung
Siu-Lun Leung
MHMei-Ki Ho
Mei-Ki Ho
YLYun-chung Leung
Yun-chung Leung
Colorectal cancer (CRC) has been proven to be highly reliant on arginine availability. Limiting arginine-rich foods or treating patients with arginine-depleting enzymes arginine deiminase (ADI) or arginase can suppress colon cancer. However, arginase and ADI are not the best drug candidates for CRC. Ornithine, the product of arginase, can enhance the supply of polyamine, which favors CRC cell growth, while citrulline, the product of ADI, faces the problem of arginine recycling due to the overexpression of argininosuccinate synthetase (ASS). Biosynthetic arginine decarboxylase (ADC), an enzyme that catalyzes the conversion of arginine to agmatine and carbon dioxide, may be a better choice as it combines both arginine depletion and suppression of intracellular polyamine synthesis via its product agmatine. ADC has anti-tumor potential yet has received much less attention than the other two arginine-depleting enzymes. In order to gain a better understanding of ADC, the preparation and the anti-cancer properties of this enzyme were explored in this study. When tested in vitro, ADC inhibited the proliferation of three colorectal cancer cell lines regardless of their ASS cellular expression. In contrast, ADC had a lesser cytotoxic effect on the human foreskin fibroblasts and rat primary hepatocytes. Further in vitro studies revealed that ADC induced S and G2/M phase cell-cycle arrest and apoptosis in HCT116 and LoVo cells. ADC-induced apoptosis in HCT116 cells followed the mitochondrial apoptotic pathway and was caspase-3-dependent. With all results obtained, we suggest that arginine is a potential target for treating colorectal cancer with ADC, and the anti-cancer properties of ADC should be more deeply investigated in the future.

8 November 2018 in ChemCatChem
Verified
Journal Article
Closed access
PDF file
XWXinlei Wei
Xinlei Wei
LXLeipeng Xie
Leipeng Xie
YZYi‐Heng P. Job Zhang
Yi‐Heng P. Job Zhang
CYChun You
Chun You

1 January 2012 in Ironmaking & Steelmaking: Processes, Products and Applications
Verified
Journal Article
Closed access
YLYang Luo
Yang Luo
JZJ M Zhang
J M Zhang
XWXinlei Wei
Xinlei Wei
CXC Xiao
C Xiao
ZHZ F Hu
Z F Hu
SCS D Chen
S D Chen

16 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
XWXinlei Wei
Xinlei Wei
XYXue Yang
Xue Yang
CHCongcong Hu
Congcong Hu
QLQiangzi Li
Qiangzi Li
QLQianqian Liu
Qianqian Liu
CYChun You
Chun You
In vitro biotransformation (ivBT) facilitated by in vitro synthetic enzymatic biosystems (ivSEBs) has emerged as a highly promising biosynthetic platform. Several ivSEBs have been constructed to produce poly-3-hydroxybutyrate (PHB) via acetyl-coenzyme A (acetyl-CoA). However, some systems are hindered by their reliance on costly ATP, limiting their practicality. This study presents the design of an ATP-free ivSEB for one-pot PHB biosynthesis via acetyl-CoA utilizing starch-derived maltodextrin as the sole substrate. Stoichiometric analysis indicates this ivSEB can self-maintain NADP+/NADPH balance and achieve a theoretical molar yield of 133.3%. Leveraging simple one-pot reactions, our ivSEBs achieved a near-theoretical molar yield of 125.5%, the highest PHB titer (208.3 mM, approximately 17.9 g/L) and the fastest PHB production rate (9.4 mM/h, approximately 0.8 g/L/h) among all the reported ivSEBs to date, and demonstrated easy scalability. This study unveils the promising potential of ivBT for the industrial-scale production of PHB and other acetyl-CoA-derived chemicals from starch.

1 July 2022 in BioDesign Research
Verified
Journal Article
Open access
PDF file
GLGuowei Li
Guowei Li
XWXinlei Wei
Xinlei Wei
RWRanran Wu
Ranran Wu
WZWei Zhou
Wei Zhou
YLYunjie Li
Yunjie Li
CYChun You
Chun You
Maltose is a natural α-(1,4)-linked disaccharide with wide applications in food industries and microbial fermentation. However, maltose has scarcely been used for in vitro biosynthesis, possibly because its phosphorylation by maltose phosphorylase (MP) yields β-glucose 1-phosphate (β-G1P) that cannot be utilized by α-phosphoglucomutase (α-PGM) commonly found in in vitro synthetic enzymatic biosystems previously constructed by our group. Herein, we designed an in vitro synthetic enzymatic reaction module comprised of MP, β-phosphoglucomutase (β-PGM), and polyphosphate glucokinase (PPGK) for the stoichiometric conversion of each maltose molecule to two glucose 6-phosphate (G6P) molecules. Based on this synthetic module, we further constructed two in vitro synthetic biosystems to produce bioelectricity and fructose 1,6-diphosphate (FDP), respectively. The 14-enzyme biobattery achieved a Faraday efficiency of 96.4 and a maximal power density of 0.6mW/cm2, whereas the 5-enzyme in vitro FDP-producing biosystem yielded 187.0mM FDP from 50g/L (139mM) maltose by adopting a fed-batch substrate feeding strategy. Our study not only suggests new application scenarios for maltose but also provides novel strategies for the high-efficient production of bioelectricity and value-added biochemicals.